Elena Ongaro - Publications

Prolonged response to combined BRAF and MEK inhibition in BRAF mutant colorectal cancer, a case report.

Journal: Frontiers in oncology

Published: March 13, 2026

HLA-G alleles in Italian patients with locally advanced rectal cancer (LARC).

Journal: Human immunology

Published: November 17, 2025

Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 04, 2025

Triplet chemotherapy combined with anti Epidermal Growth Factor Receptor treatment in RAS wild-type colorectal cancer: a network metanalysis.

Journal: The oncologist

Published: October 12, 2025

Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: comparative outcomes and AI-guided treatment selection.

Journal: The oncologist

Published: October 07, 2025

A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 13, 2025

Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy.

Journal: ESMO open

Published: September 07, 2025

Anti-HER2 Therapies in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.

Journal: The oncologist

Published: June 06, 2025

Fournier's Gangrene During Lenvatinib Treatment for Hepatocarcinoma.

Journal: Cureus

Published: April 24, 2025

FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: An individual patient data-based pooled analysis of randomized trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 25, 2025

Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial.

Journal: ESMO open

Published: March 16, 2025

Precision oncology in biliary tract cancer: the emerging role of liquid biopsy.

Journal: ESMO open

Published: December 29, 2024